What is the recommended use of bupropion (Wellbutrin) for a patient with adjustment disorder with depressed mood?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bupropion (Wellbutrin) is not recommended as first-line treatment for adjustment disorder with depressed mood, as it is FDA-approved only for major depressive disorder (MDD) and seasonal affective disorder (SAD), not for adjustment disorders.

FDA-Approved Indications

Bupropion is FDA-approved exclusively for:

  • Major depressive disorder (MDD) 1
  • Seasonal affective disorder (SAD) 1
  • Smoking cessation (as Zyban formulation)

The FDA label explicitly states that bupropion's efficacy was established in controlled trials of patients meeting DSM criteria for MDD, not adjustment disorders 1.

Key Clinical Distinction

Adjustment disorder with depressed mood differs fundamentally from MDD:

  • Adjustment disorder is a stress-related condition triggered by identifiable psychosocial stressors
  • Symptoms are typically less severe and time-limited (usually resolving within 6 months after stressor removal)
  • MDD requires more pervasive symptoms meeting specific DSM criteria for duration and severity

The evidence base for bupropion exists only for MDD, where it demonstrates efficacy comparable to SSRIs 2, 3, 4. No studies have evaluated bupropion specifically for adjustment disorders.

Treatment Approach for Adjustment Disorder with Depressed Mood

First-line treatment should be:

  1. Psychotherapy - particularly problem-solving therapy, brief supportive therapy, or cognitive-behavioral approaches targeting the specific stressor
  2. Watchful waiting with supportive interventions, as many cases resolve spontaneously once the stressor is removed or adaptation occurs

Consider pharmacotherapy only if:

  • Symptoms are severe and significantly impairing function
  • Psychotherapy alone is insufficient after 4-6 weeks
  • The clinical picture evolves to meet full criteria for MDD

If Antidepressant Treatment Becomes Necessary

If the severity warrants medication (suggesting possible evolution to MDD):

The 2008 American College of Physicians guideline recommends selecting between cognitive behavioral therapy or second-generation antidepressants after discussing effects, adverse events, cost, and patient preferences 4. Among second-generation antidepressants, SSRIs are typically preferred as first-line agents due to:

  • Broader evidence base
  • Better tolerability profile in most patients
  • Lower seizure risk compared to bupropion

Bupropion may be considered as an alternative if:

  • Patient has prominent fatigue, low energy, or decreased motivation (bupropion shows efficacy for these symptoms in MDD) 5
  • Sexual dysfunction is a concern (bupropion has significantly lower rates than SSRIs) 2
  • Patient is also attempting smoking cessation 6
  • Patient has comorbid obesity and depressed mood (naltrexone-bupropion combination may be reasonable) 7

Critical Safety Considerations

Before prescribing bupropion, screen for contraindications:

  • Seizure history or risk factors (stroke, brain metastases, eating disorders) - absolute contraindication 6, 1
  • Current or recent (within 14 days) MAOI use 1
  • Uncontrolled hypertension 7
  • Bulimia or anorexia nervosa (higher seizure incidence) 8

Monitor closely for:

  • Suicidal thoughts and behaviors, especially in patients under age 24 1
  • Neuropsychiatric symptoms including anxiety, agitation, or mood destabilization 6, 9
  • Seizures (dose-dependent risk; maximum 450 mg/day immediate-release, 400 mg/day sustained-release) 1

Dosing If Prescribed

Standard bupropion XL dosing for depression:

  • Start: 150 mg once daily in the morning 1
  • After 4 days: May increase to target dose of 300 mg once daily 1
  • Take in morning to minimize insomnia risk 7
  • Swallow whole; do not crush, divide, or chew 1

Dose adjustments required for:

  • Moderate-severe hepatic impairment: Maximum 150 mg every other day 1
  • Renal impairment (GFR <90 mL/min): Consider dose/frequency reduction 1

Common Pitfalls to Avoid

  1. Do not prescribe bupropion for adjustment disorder simply because depressed mood is present - the diagnosis matters for treatment selection
  2. Do not overlook psychotherapy - it should be offered first for adjustment disorders
  3. Do not ignore seizure risk factors - carefully screen history before prescribing
  4. Do not combine with MAOIs - requires 14-day washout period 1
  5. Do not assume bupropion is anxiolytic - it may initially worsen anxiety symptoms in some patients 10

Bottom Line

For true adjustment disorder with depressed mood, psychotherapy is the evidence-based first-line treatment. If symptoms are severe enough to warrant antidepressant medication, this suggests the clinical picture may actually represent MDD rather than adjustment disorder, and diagnosis should be reassessed. In that case, bupropion is a reasonable option among second-generation antidepressants, particularly when targeting specific symptom profiles (low energy, sexual dysfunction concerns, smoking cessation) or when SSRIs are contraindicated or poorly tolerated.

References

Guideline

smoking cessation, version 1.2016, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Guideline

american association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2016

Research

Bupropion and Anxiety: A Brief Review.

Human psychopharmacology, 2025

Related Questions

What are the appropriate next steps for a patient on bupropion (Wellbutrin) who continues to have low motivation and depressive symptoms?
How should bupropion be initiated for depression and an immediate‑release stimulant be added for ADHD symptoms, including dosing, titration, monitoring, and contraindications?
Can a 12-year-old patient with depression treated with sertraline (Zoloft) 25 mg daily and ADHD be started on bupropion XL (Wellbutrin) 150 mg?
What are the next steps for a patient who has been taking bupropion XL (bupropion) 300 mg daily for at least four to six weeks without improvement in depressive symptoms?
What is the recommended starting dose and titration schedule for bupropion extended‑release (bupropion XL) in a patient with treatment‑resistant depression who has hyponatremia, irritable bowel syndrome with diarrhea, weight gain, diabetes, fatigue, low energy, and anhedonia?
After ureteroscopy with intracorporeal lithotripsy, what happens to multiple stone fragments smaller than 4 mm after ureteral stent removal?
What volume of intravenous fluid is recommended for patients with necrotizing pancreatitis?
How does cluster dextrin (highly branched cyclic dextrin) compare to maltodextrin in terms of absorption rate, glycemic impact, osmolality, gastrointestinal tolerance, and recommended dosing for athletes?
I am 6 weeks post‑aquablation and recently had clot evacuation with transurethral resection of prostate and fulguration of bleeders; what postoperative care should I follow and what warning signs indicate I need urgent medical attention?
What are the gastrointestinal effects of gamma‑butyrolactone (GBL) and its active metabolite gamma‑hydroxybutyrate (GHB)?
What is the recommended assessment and management for malignant catatonia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.